product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Lumican Protein, CF
catalog :
2846-LU-050
quantity :
50 ug
price :
432 USD
more info or order :
citations: 9
Reference
Karamanou K, Franchi M, Proult I, Rivet R, Vynios D, Br xe9 zillon S. Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers. Cells. 2021;10: pubmed publisher
Chen D, Smith L, Khandekar G, Patel P, Yu C, Zhang K, et al. Distinct effects of different matrix proteoglycans on collagen fibrillogenesis and cell-mediated collagen reorganization. Sci Rep. 2020;10:19065 pubmed publisher
Asega A, Menezes M, Trevisan Silva D, Cajado Carvalho D, Bertholim L, Oliveira A, et al. Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases. Sci Rep. 2020;10:12912 pubmed publisher
Li X, Kang Y, Roife D, Lee Y, Pratt M, Perez M, et al. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Oncogene. 2017;36:5432-5438 pubmed publisher
Karamanou K, Franchi M, Piperigkou Z, Perreau C, Maquart F, Vynios D, et al. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition. Sci Rep. 2017;7:45138 pubmed publisher
Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, et al. Transforming Growth Factor-? Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clin Cancer Res. 2016;22:4934-4946 pubmed
Zhang Y, Mao X, Schwend T, Littlechild S, Conrad G. Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2013;54:1014-25 pubmed publisher
Krishnan A, Li X, Kao W, Viker K, Butters K, Masuoka H, et al. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab Invest. 2012;92:1712-25 pubmed publisher
Seomun Y, Joo C. Lumican induces human corneal epithelial cell migration and integrin expression via ERK 1/2 signaling. Biochem Biophys Res Commun. 2008;372:221-5 pubmed publisher
product information
brand :
R&D Systems
master code :
2846-LU
SKU :
2846-LU-050
product name :
Recombinant Human Lumican Protein, CF
unit size :
50 ug
seo description :
The Recombinant Human Lumican Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Lumican Protein, CF has been validated for the following applications: Bioactivity.
target :
Lumican
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
dilution :
Bioactivity
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Human
observed molecular weight :
55-65 kDa, reducing conditions
theoretical molecular weight :
37.5 kDa
gene symbol :
LUM
details of functionality :
Measured by the ability of the immobilized protein to support the adhesion of BCE C/D-1b bovine corneal endothelial cells. When 5 x 104 cells per well are added to Recombinant Human Lumican coated plates (10 ╡g/mL, 100 ╡L/well), 35% will adhere after 50 minutes at 37 ░C. Optimal dilutions should be determined by each laboratory for each application.
endotoxin note :
<1.0 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
P51884
applications :
Bioactivity
source :
NS0-derived Recombinant Human Lumican Protein, CF
USD :
432 USD
alt names :
KSPG lumican, LDC, LUM, lumican, lumican proteoglycan, SLRR2D, SLRR2DLDCKeratan sulfate proteoglycan lumican
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.